Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Abpro Corporation, a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for t... Abpro Corporation, a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers, and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as IE LAB Inc. and changed its name to Abpro Corporation in October 2007. Abpro Corporation was incorporated in 2004 and is headquartered in Woburn, Massachusetts. Mehr anzeigen
Business combination closed November 13, 2024Raised $10 million of gross proceeds in connection with the business combinationAgreements are in place with Yorkville for up to a $50 million standby...
WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening...
Abpro to receive up to $1.1 billion, including a $30 million upfront equity investment, clinical funding, milestones, and royalties Abpro grants exclusive license to Abpro Bio, formerly named...
IRVINE, Calif., Feb. 15 /PRNewswire/ -- C. K. Cooper & Company, an independent, full-service investment bank focused on the energy sector and headquartered in Irvine, California, announced today...
IRVINE, Calif., May 30 /PRNewswire/ -- C. K. Cooper & Company, an independent, full-service investment bank, announced today that Director of Research Phil McPherson has left the firm to pursue...
OVERLAND PARK, Kan., May 29 /PRNewswire-FirstCall/ -- Tortoise Capital Resources Corp. (NYSE:TTO) today announced that it has invested $7.5 million in a newly formed partnership, Abraxas Energy...
NEW YORK, Nov. 4 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Monday, November 7, 2005 on the following American Stock Exchange, Nasdaq Stock Market...
RNS Number:4400U Associated British Ports Hldgs PLC 20 January 2004 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Associated British...
RNS Number:4399U Associated British Ports Hldgs PLC 20 January 2004 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Associated British...
RNS Number:9036T Associated British Ports Hldgs PLC 6 January 2004 Letter to RNS I am writing to advise you of the timetable for the publication of the Company's Annual Report and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.27 | -20.7692307692 | 1.3 | 1.35 | 1.02 | 38310 | 1.13521263 | CS |
| 4 | -0.57 | -35.625 | 1.6 | 1.6999 | 1.02 | 84698 | 1.35947559 | CS |
| 12 | -4.17 | -80.1923076923 | 5.2 | 8.8 | 0.95 | 868949 | 1.9637671 | CS |
| 26 | -4.17 | -80.1923076923 | 5.2 | 8.8 | 0.95 | 868949 | 1.9637671 | CS |
| 52 | -4.17 | -80.1923076923 | 5.2 | 8.8 | 0.95 | 868949 | 1.9637671 | CS |
| 156 | -4.17 | -80.1923076923 | 5.2 | 8.8 | 0.95 | 868949 | 1.9637671 | CS |
| 260 | -4.17 | -80.1923076923 | 5.2 | 8.8 | 0.95 | 868949 | 1.9637671 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| CLEUChina Liberal Education Holdings Ltd | US$ 0,1647 (11,13%) | 12,25M |
| KITTNauticus Robotics Inc | US$ 2,29 (46,79%) | 9,56M |
| TDTHTrident Digital Tech Holdings Ltd | US$ 1,89 (98,95%) | 5,31M |
| ORKTOrangeKloud Technology Inc | US$ 1,76 (28,47%) | 3,19M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0,0366 (-8,50%) | 2,04M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
